Levofloxacin Solution
NDC Package 72888-142-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Levofloxacin solution is levofloxacin is used to treat a variety of bacterial infections. This formulation utilizes a solution delivery system. Marketed by Advagen Pharma Limited, this product is identified by NDC 72888-142 and is authorized under FDA application ANDA078282.

Identification & Billing

NDC Package Code
72888-142-22
Package Description
1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
72888014222
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Levofloxacin
Non-Proprietary Name
Levofloxacin
Substance Name
Levofloxacin
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Usage Information
Levofloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Advagen Pharma Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA078282
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-22-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72888-142-22 identifies a specific commercial package of 1 bottle in 1 carton / 5 ml in 1 bottle of Levofloxacin, a human prescription drug labeled by Advagen Pharma Limited. This solution is formulated for ophthalmic use and contains levofloxacin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advagen Pharma Limited on February 22, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Levofloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Advagen Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72888014222. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72888-142-22
11-Digit CMS (5-4-2)
72888-0142-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.